DoubleLine ETF Adviser’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,551
Closed -$1.22M 172
2024
Q3
$1.22M Sell
5,551
-385
-6% -$79.7K 0.3% 87
2024
Q2
$1.17M Sell
5,936
-227
-4% -$46.9K 0.31% 75
2024
Q1
$1.33M Buy
6,163
+136
+2% +$28.6K 0.34% 78
2023
Q4
$1.27M Buy
6,027
+485
+9% +$103K 0.37% 70
2023
Q3
$1.11M Buy
5,542
+356
+7% +$70.8K 0.4% 60
2023
Q2
$961K Buy
5,186
+1,114
+27% +$206K 0.35% 73
2023
Q1
$780K Sell
4,072
-1,005
-20% -$182K 0.33% 72
2022
Q4
$854K Buy
+5,077
New +$882K 0.44% 57

Other funds holding CME

DoubleLine ETF Adviser's CME Position: Q4 2024 in Review

DoubleLine ETF Adviser sold out of CME Group (CME) in Q4 2024, closing a stake of 5,551 shares — an estimated $1.22M sold.

DoubleLine ETF Adviser first reported a position in CME in Q4 2022 and held it in 8 quarters. The position peaked at $1.33M in Q1 2024. 1,500 funds tracked by Wall St. Rank hold CME as of Q4 2024.

  • DoubleLine ETF Adviser reported no remaining CME Group position as of Q4 2024 after selling out during the quarter.
  • DoubleLine ETF Adviser sold 5,551 CME Group shares in Q4 2024, an estimated $1.22M.
  • DoubleLine ETF Adviser first reported a position in CME Group in Q4 2022 and held it in 8 quarters.
  • DoubleLine ETF Adviser's CME Group position peaked at $1.33M in Q1 2024.
  • 1,500 funds tracked by Wall St. Rank held CME Group as of Q4 2024.

Based on DoubleLine ETF Adviser's 13F filing for Q4 2024, filed 14 Feb 2025.